A Pharmacokinetic Analysis of Posaconazole in Lung Transplant Recipients (MK-5592-105)
Status:
Terminated
Trial end date:
2014-01-16
Target enrollment:
Participant gender:
Summary
This single site study will examine plasma and alveolar compartment (AC) levels of
posaconazole in cystic fibrosis (CF) and non-cystic fibrosis (non-CF) lung transplant
recipients receiving routine post-operative anti-fungal prophylaxis. Invasive fungal
infection rates will be assessed following transplantation.